Over 100 mutations in the LRRK2 gene have been demonstrated to be associated with PD development [6] by preventing mitochondrial fission [7], attenuating microglial motility [8], and increasing neural death [9–12]. This evidence concerns the gene LRRK2 and Parkinson disease.